Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

PNAS 104 (1): 134-138

Copyright © 2007 by the National Academy of Sciences.


BIOLOGICAL SCIENCES / CELL BIOLOGY / MEDICAL SCIENCES

Bcl10 and Malt1 control lysophosphatidic acid-induced NF-{kappa}B activation and cytokine production

Stefanie Klemm*, Stephanie Zimmermann*, Christian Peschel*, Tak W. Mak{dagger},{ddagger}, and Jürgen Ruland*,{ddagger}

*Third Medical Department, Technical University of Munich, Klinikum Rechts der Isar, Ismaninger Strasse 22, 81675 Munich, Germany; and {dagger}The Campbell Family Institute for Breast Cancer Research and Ontario Cancer Institute, University Health Network, University of Toronto, Toronto, ON, Canada M5G 2C1

Contributed by Tak W. Mak, September 25, 2006

Abstract: Lysophosphatidic acid (LPA) is a potent bioactive phospholipid that stimulates a variety of cellular responses by acting on cognate G protein-coupled receptors (GPCRs). There is increasing evidence that LPA signaling reprograms gene expression, but the GPCR-induced pathways connecting LPA receptor stimulation to downstream transcription factors are not well characterized. Here, we identify the adapter proteins Bcl10 and Malt1 as essential mediators of LPA-induced NF-{kappa}B activation. Both proteins were previously known to activate NF-{kappa}B in response to antigen receptor ligation on lymphocytes, but their functions in nonimmune cells are still largely undefined. By using murine embryonic fibroblasts from Bcl10- or Malt1-deficient mice as a genetic model, we report that Bcl10 and Malt1 are critically required for the degradation of I{kappa}B-{alpha} and the subsequent NF-{kappa}B induction in response to LPA stimulation. Bcl10 and Malt1 cooperate with PKCs selectively for LPA-induced NF-{kappa}B activation but are dispensable for the activation of the Jnk, p38, Erk MAP kinase, and Akt signaling pathways. In a biological readout, we demonstrate that LPA-induced IL-6 production is abolished in the absence of Bcl10. Thus, our results identify a NF-{kappa}B-inducing signaling pathway downstream of GPCRs and reveal previously unrecognized functions for Bcl10/Malt1 signaling in nonimmune cells.

Key Words: G protein-coupled receptor • signal transduction


Author contributions: J.R. and T.W.M. designed research; S.K. and S.Z. performed research; S.K., S.Z., C.P., T.W.M., and J.R. analyzed data; and S.K., T.W.M., and J.R. wrote the paper.

The authors declare no conflict of interest.

{ddagger}To whom correspondence may be addressed. E-mail: tmak{at}uhnres.utoronto.ca or jruland{at}lrz.tum.de

© 2007 by The National Academy of Sciences of the USA


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
MALT1 Protease: A New Therapeutic Target in B Lymphoma and Beyond?.
L. M. McAllister-Lucas, M. Baens, and P. C. Lucas (2011)
Clin. Cancer Res. 17, 6623-6631
   Abstract »    Full Text »    PDF »
The E3 Ubiquitin Ligase Mind Bomb-2 (MIB2) Protein Controls B-cell CLL/Lymphoma 10 (BCL10)-dependent NF-{kappa}B Activation.
C. C. Stempin, L. Chi, J. P. Giraldo-Vela, A. A. High, H. Hacker, and V. Redecke (2011)
J. Biol. Chem. 286, 37147-37157
   Abstract »    Full Text »    PDF »
Specific effects of BCL10 Serine mutations on phosphorylations in canonical and noncanonical pathways of NF-{kappa}B activation following carrageenan.
S. Bhattacharyya, A. Borthakur, A. N. Anbazhagan, S. Katyal, P. K. Dudeja, and J. K. Tobacman (2011)
Am J Physiol Gastrointest Liver Physiol 301, G475-G486
   Abstract »    Full Text »    PDF »
T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1.
J. Staal, Y. Driege, T. Bekaert, A. Demeyer, D. Muyllaert, P. Van Damme, K. Gevaert, and R. Beyaert (2011)
EMBO J. 30, 1742-1752
   Abstract »    Full Text »    PDF »
CARMA3 is Crucial for EGFR-Induced Activation of NF-{kappa}B and Tumor Progression.
T. Jiang, B. Grabiner, Y. Zhu, C. Jiang, H. Li, Y. You, J. Lang, M.-C. Hung, and X. Lin (2011)
Cancer Res. 71, 2183-2192
   Abstract »    Full Text »    PDF »
Thrombin-dependent NF-{kappa}B Activation and Monocyte/Endothelial Adhesion Are Mediated by the CARMA3{middle dot}Bcl10{middle dot}MALT1 Signalosome.
P. C. Delekta, I. J. Apel, S. Gu, K. Siu, Y. Hattori, L. M. McAllister-Lucas, and P. C. Lucas (2010)
J. Biol. Chem. 285, 41432-41442
   Abstract »    Full Text »    PDF »
Tumor Necrosis Factor Receptor-associated Factor-6 and Ribosomal S6 Kinase Intracellular Pathways Link the Angiotensin II AT1 Receptor to the Phosphorylation and Activation of the I{kappa}B Kinase Complex in Vascular Smooth Muscle Cells.
P. Doyon and M. J. Servant (2010)
J. Biol. Chem. 285, 30708-30718
   Abstract »    Full Text »    PDF »
Protein Phosphatase 2A Acts as a Mitogen-activated Protein Kinase Kinase Kinase 3 (MEKK3) Phosphatase to Inhibit Lysophosphatidic Acid-induced I{kappa}B Kinase {beta}/Nuclear Factor-{kappa}B Activation.
W. Sun, H. Wang, X. Zhao, Y. Yu, Y. Fan, H. Wang, X. Wang, X. Lu, G. Zhang, S. Fu, et al. (2010)
J. Biol. Chem. 285, 21341-21348
   Abstract »    Full Text »    PDF »
Phosphorylation of Thr-516 and Ser-520 in the Kinase Activation Loop of MEKK3 Is Required for Lysophosphatidic Acid-mediated Optimal I{kappa}B Kinase {beta} (IKK{beta})/Nuclear Factor-{kappa}B (NF-{kappa}B) Activation.
W. Sun, N. Ge, Y. Yu, S. Burlingame, X. Li, M. Zhang, S. Ye, S. Fu, and J. Yang (2010)
J. Biol. Chem. 285, 7911-7918
   Abstract »    Full Text »    PDF »
B-cell CLL/Lymphoma 10 (BCL10) Is Required for NF-{kappa}B Production by Both Canonical and Noncanonical Pathways and for NF-{kappa}B-inducing Kinase (NIK) Phosphorylation.
S. Bhattacharyya, A. Borthakur, S. Tyagi, R. Gill, M. L. Chen, P. K. Dudeja, and J. K. Tobacman (2010)
J. Biol. Chem. 285, 522-530
   Abstract »    Full Text »    PDF »
Epigenetic Loss of Mucosa-Associated Lymphoid Tissue 1 Expression in Patients with Oral Carcinomas.
T. Chiba, G. Maeda, S. Kawashiri, K. Kato, and K. Imai (2009)
Cancer Res. 69, 7216-7223
   Abstract »    Full Text »    PDF »
CXCL8/IL8 Stimulates Vascular Endothelial Growth Factor (VEGF) Expression and the Autocrine Activation of VEGFR2 in Endothelial Cells by Activating NF{kappa}B through the CBM (Carma3/Bcl10/Malt1) Complex.
D. Martin, R. Galisteo, and J. S. Gutkind (2009)
J. Biol. Chem. 284, 6038-6042
   Abstract »    Full Text »    PDF »
Multiple Protein Domains Mediate Interaction between Bcl10 and MALT1.
F. D. Langel, N. A. Jain, J. S. Rossman, L. M. Kingeter, A. K. Kashyap, and B. C. Schaefer (2008)
J. Biol. Chem. 283, 32419-32431
   Abstract »    Full Text »    PDF »
{beta}-Arrestin 2 is required for lysophosphatidic acid-induced NF-{kappa}B activation.
J. Sun and X. Lin (2008)
PNAS 105, 17085-17090
   Abstract »    Full Text »    PDF »
Lipopolysaccharide activates NF-{kappa}B by TLR4-Bcl10-dependent and independent pathways in colonic epithelial cells.
S. Bhattacharyya, P. K. Dudeja, and J. K. Tobacman (2008)
Am J Physiol Gastrointest Liver Physiol 295, G784-G790
   Abstract »    Full Text »    PDF »
Activation of NF-{kappa}B1 by OX40 Contributes to Antigen-Driven T Cell Expansion and Survival.
J. Song, T. So, and M. Croft (2008)
J. Immunol. 180, 7240-7248
   Abstract »    Full Text »    PDF »
Toll-like Receptor 4 Mediates Induction of the Bcl10-NF{kappa}B-Interleukin-8 Inflammatory Pathway by Carrageenan in Human Intestinal Epithelial Cells.
S. Bhattacharyya, R. Gill, M. L. Chen, F. Zhang, R. J. Linhardt, P. K. Dudeja, and J. K. Tobacman (2008)
J. Biol. Chem. 283, 10550-10558
   Abstract »    Full Text »    PDF »
Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti.
H. Sebban-Benin, A. Pescatore, F. Fusco, V. Pascuale, J. Gautheron, S. Yamaoka, A. Moncla, M. V. Ursini, and G. Courtois (2007)
Hum. Mol. Genet. 16, 2805-2815
   Abstract »    Full Text »    PDF »
Malt1 ubiquitination triggers NF-{kappa}B signaling upon T-cell activation.
A. Oeckinghaus, E. Wegener, V. Welteke, U. Ferch, S. C. Arslan, J. Ruland, C. Scheidereit, and D. Krappmann (2007)
EMBO J. 26, 4634-4645
   Abstract »    Full Text »    PDF »
Bcl10 mediates LPS-induced activation of NF-{kappa}B and IL-8 in human intestinal epithelial cells.
S. Bhattacharyya, A. Borthakur, N. Pant, P. K. Dudeja, and J. K. Tobacman (2007)
Am J Physiol Gastrointest Liver Physiol 293, G429-G437
   Abstract »    Full Text »    PDF »
CARD-Bcl10-Malt1 Signalosomes: Missing Link to NF-{kappa}B.
E. Wegener and D. Krappmann (2007)
Sci. STKE 2007, pe21
   Abstract »    Full Text »    PDF »
CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation.
B. C. Grabiner, M. Blonska, P.-C. Lin, Y. You, D. Wang, J. Sun, B. G. Darnay, C. Dong, and X. Lin (2007)
Genes & Dev. 21, 984-996
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882